Superdisintegrants Market Introduction 

Superdisintegrants are a type of excipient used in the pharmaceutical industry to improve the disintegration and dissolution of oral dosage forms such as tablets, capsules, and powders. Superdisintegrants are added to formulations to promote rapid disintegration, allowing the active pharmaceutical ingredient (API) to dissolve and be absorbed more quickly in the body.Superdisintegrants are essential components of fast-dissolving dosage forms, particularly for patients who have difficulty swallowing traditional tablets or capsules. They can also improve the bioavailability and efficacy of certain drugs by facilitating their rapid absorption in the body.Superdisintegrants are available in various forms such as croscarmellose sodium, sodium starch glycolate, crospovidone, and low-substituted hydroxypropyl cellulose (L-HPC). These superdisintegrants are widely used in the pharmaceutical industry to formulate immediate-release tablets and capsules, orally disintegrating tablets, and other fast-dissolving dosage forms.The global superdisintegrants market is expected to grow at a significant rate due to the increasing demand for fast-dissolving dosage forms, the growing prevalence of chronic diseases, and the rising demand for generic drugs.

Superdisintegrants Market  Size

The global superdisintegrants market size was valued at USD 328.1 million in 2020 and is projected to reach USD 527.3 million by 2028, growing at a CAGR of 6.0% from 2021 to 2028.The demand for superdisintegrants is expected to continue to grow due to the increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer. These diseases require regular medication, and superdisintegrants play a vital role in the formulation of fast-dissolving dosage forms that can improve medication adherence and patient compliance.Additionally, the growing demand for generic drugs and the need for cost-effective treatments are expected to drive the growth of the superdisintegrants market. The use of superdisintegrants in generic drugs can reduce the manufacturing costs, making these drugs more affordable for patients.North America is expected to hold the largest share of the superdisintegrants market due to the presence of a large number of pharmaceutical companies and the high prevalence of chronic diseases in the region. Europe is also expected to be a significant market for superdisintegrants due to the increasing demand for fast-dissolving dosage forms and the growing use of generic drugs.Overall, the global superdisintegrants market is expected to grow in the coming years, driven by the increasing demand for fast-dissolving dosage forms and the growing need for cost-effective treatments for chronic diseases.

Superdisintegrants Market  Share

Based on type, the sodium starch glycolate segment dominated the global superdisintegrants market with a revenue share of 35.2% in 2020. Sodium starch glycolate is widely used as a superdisintegrant in the pharmaceutical industry due to its superior swelling and disintegration properties. It is also used in a wide range of dosage forms such as tablets, capsules, and granules.Based on application, the tablet segment held the largest share of the superdisintegrants market in 2020, accounting for 52.3% of the total revenue. This can be attributed to the widespread use of tablets as a dosage form for oral drug delivery.Based on region, North America dominated the global superdisintegrants market with a revenue share of 36.5% in 2020. This can be attributed to the presence of a large number of pharmaceutical companies and the high prevalence of chronic diseases in the region. Europe and the Asia Pacific are also significant markets for superdisintegrants, driven by the growing demand for fast-dissolving dosage forms and the increasing use of generic drugs.Some of the key players operating in the global superdisintegrants market include Ashland Global Holdings Inc., BASF SE, DowDupont Inc., Roquette Frères, and JRS Pharma GmbH & Co. KG. These players are focusing on product development and innovation to meet the growing demand for superdisintegrants in the pharmaceutical industry.

Superdisintegrants Market  Trends

Here are some of the key trends in the superdisintegrants market:

1. Increasing demand for orally disintegrating tablets (ODTs): ODTs are gaining popularity due to their ease of administration and improved patient compliance, especially among geriatric and pediatric populations. Superdisintegrants are essential for the formulation of ODTs, and the increasing demand for ODTs is expected to drive the growth of the superdisintegrants market.
2. Growing demand for generic drugs: The increasing cost of healthcare and the growing prevalence of chronic diseases have led to a rise in the demand for generic drugs. Superdisintegrants are widely used in the formulation of generic drugs, as they can improve drug dissolution and absorption, thereby enhancing the efficacy of the drug.
3. Development of novel superdisintegrants: Researchers and manufacturers are focusing on developing new and more efficient superdisintegrants to improve drug delivery and patient compliance. For instance, cross-linked polymers and natural superdisintegrants such as plantago ovata and psyllium have shown promising results in improving drug dissolution and absorption.
4. Increasing focus on sustainability: The pharmaceutical industry is increasingly focusing on sustainability and reducing its environmental footprint. Manufacturers of superdisintegrants are developing sustainable alternatives to synthetic superdisintegrants, such as natural and biodegradable materials, to meet the growing demand for eco-friendly products.
5. Advancements in drug delivery technology: The development of advanced drug delivery technologies such as 3D printing and nanotechnology is expected to drive the demand for superdisintegrants. These technologies require fast-dissolving dosage forms that can be easily administered and absorbed, and superdisintegrants play a crucial role in the formulation of such dosage forms.

Superdisintegrants Market Driving factors

Here are some of the key driving factors in the superdisintegrants market:

1. Increasing demand for orally disintegrating tablets (ODTs): ODTs are becoming more popular due to their ease of administration, improved patient compliance, and better absorption of drugs. Superdisintegrants are critical components in the formulation of ODTs, and the increasing demand for ODTs is expected to drive the growth of the superdisintegrants market.
2. Growing demand for generic drugs: The growing prevalence of chronic diseases and the increasing cost of healthcare have led to a rise in the demand for generic drugs. Superdisintegrants are widely used in the formulation of generic drugs to improve drug dissolution and absorption, thereby enhancing the efficacy of the drug.
3. Increasing R&D activities: Research and development activities in the superdisintegrants market are leading to the development of novel and more efficient superdisintegrants. Manufacturers are investing heavily in R&D to develop new superdisintegrants that offer better performance and improved drug delivery.
4. Advancements in drug delivery technology: The development of advanced drug delivery technologies such as 3D printing and nanotechnology is driving the demand for superdisintegrants. These technologies require fast-dissolving dosage forms that can be easily administered and absorbed, and superdisintegrants play a crucial role in the formulation of such dosage forms.
5. Increasing focus on patient compliance: Improving patient compliance is a critical factor in the success of any drug therapy. Superdisintegrants play a crucial role in the development of dosage forms that are easy to administer and offer improved patient compliance, leading to better treatment outcomes.

Superdisintegrants Market  Reginal Analysis

The superdisintegrants market can be analyzed regionally as follows:

1. North America: The North American market is expected to dominate the superdisintegrants market, driven by the increasing demand for orally disintegrating tablets and the high prevalence of chronic diseases. The presence of major pharmaceutical companies in the region is also a contributing factor to market growth.
2. Europe: The European market is expected to witness significant growth due to the growing demand for generic drugs and increasing investments in research and development activities.
3. Asia-Pacific: The Asia-Pacific region is expected to witness the highest growth in the superdisintegrants market, driven by the growing population, increasing incidence of chronic diseases, and rising healthcare expenditure. The presence of a large number of pharmaceutical companies in the region and the growing demand for generic drugs are also contributing factors.
4. Middle East and Africa: The Middle East and Africa region is expected to witness moderate growth in the superdisintegrants market, driven by the growing demand for fast-dissolving dosage forms and increasing investments in the healthcare sector.
5. Latin America: The Latin American market is expected to witness steady growth due to the increasing focus on patient compliance and the growing demand for generic drugs. The presence of major pharmaceutical companies in the region is also expected to contribute to market growth.

Superdisintegrants Market  Forecasts 2030

The global superdisintegrants market is expected to witness significant growth during the forecast period of 2021-2030. The increasing demand for orally disintegrating tablets and the growing prevalence of chronic diseases are the major factors driving market growth. Additionally, the growing demand for generic drugs and increasing investments in research and development activities are expected to further boost the market.The global superdisintegrants market is expected to reach USD 634.7 million by 2030, growing at a CAGR of 7.2% from 2021 to 2030. The Asia-Pacific region is expected to witness the highest growth during the forecast period, driven by the growing population, increasing incidence of chronic diseases, and rising healthcare expenditure.The increasing demand for fast-dissolving dosage forms and the need for improved patient compliance are also expected to drive the market growth. The use of superdisintegrants in the production of orally disintegrating tablets and other fast-dissolving dosage forms is expected to increase, driving the demand for superdisintegrants in the pharmaceutical industry.The key players operating in the superdisintegrants market include Ashland Global Holdings Inc., BASF SE, DFE Pharma, JRS Pharma GmbH & Co. KG, DowDuPont Inc., Roquette Frères, among others. These players are focusing on expanding their product portfolios, investing in research and development activities, and engaging in strategic collaborations and partnerships to strengthen their market positions.

Superdisintegrants Market Key Industry Players

Some of the key players in the global superdisintegrants market are:

1. Ashland Global Holdings Inc.
2. BASF SE
3. DFE Pharma
4. JRS Pharma GmbH & Co. KG
5. DowDuPont Inc.
6. Roquette Frères
7. Asahi Kasei Corporation
8. Nippon Soda Co., Ltd.
9. Avantor, Inc.
10. Corel Pharma Chem

These companies are focusing on expanding their product portfolios, investing in research and development activities, and engaging in strategic collaborations and partnerships to strengthen their market positions. For instance, in 2021, BASF launched its new superdisintegrant, Kollidon VA64, which offers improved tablet dissolution and disintegration. Similarly, in 2020, DFE Pharma invested in a new R&D facility in Europe to expand its product offerings and strengthen its market position.